RPRD Diagnostics Receives SBIR Grant to Develop Ethnicity-Inclusive Pharmacogenetics Test for CYP2D6 Genetic Variation
Test will cover genetic variants found across race and ancestry groups, translating to improved patient outcomes across ethnic populations MILWAUKEE, USA, July 28, 2021 /EINPresswire.com/ -- RPRD (Right Patient Right Drug) Diagnostics, a leading …